1
|
Robin J, Lefeuvre S, Guihenneuc J, Cambien G, Dupuis A, Venisse N. Analytical methods and biomonitoring results in hair for the assessment of exposure to endocrine-disrupting chemicals: A literature review. CHEMOSPHERE 2024; 353:141523. [PMID: 38417485 DOI: 10.1016/j.chemosphere.2024.141523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Revised: 02/03/2024] [Accepted: 02/20/2024] [Indexed: 03/01/2024]
Abstract
Endocrine-disrupting chemicals (EDC) are compounds that alter functions of the endocrine system due to their ability to mimic or antagonize endogenous hormones, or that alter their synthesis and metabolism, causing adverse health effects. Human biomonitoring (HBM) is a reliable method to assess human exposure to chemicals through measurement in human body fluids and tissues. It identifies new sources of exposure and determines their distribution, thereby enabling detection of the most exposed populations. Blood and urine are commonly used for HBM of EDC, but their interest is limited for compounds presenting short half-lives. Hair appears as an interesting alternative insofar as it provides a large exposure window. For the present study, we evaluated the relevance of hair in determining EDC exposure. With this in mind, we undertook a literature review focusing on the bioanalytical aspects and performances of methods developed to determine EDC in hair. The literature review was performed through methodical bibliographical research. Relevant articles were identified using two scientific databases: PubMed and Web of Science, with search equations built from a combination of keywords, MeSH terms and Boolean operators. The search strategy identified 2949 articles. After duplicates were removed, and following title, abstract, and full-text screenings, only 31 were included for qualitative synthesis. Hair collection was mainly performed in the back of the head and preparation involved two processes: cutting into small pieces or grounding to powder. The off-line LC-MS/MS method remains the main technique used to assess EDC through hair. Differences regarding the validation of analytical methods and interpretation of HBM results were highlighted, suggesting a need for international harmonisation to obtain reliable and comparable results. External contamination of hair was identified as a main limitation in the interpretation of results, highlighting the need to better understand EDC transfers through hair and to develop relevant hair decontamination processes.
Collapse
Affiliation(s)
- Julien Robin
- Université de Poitiers, CNRS, Laboratoire EBI, Équipe IHES, F-86000 Poitiers, France; CHU de Poitiers, CIC-Inserm, Axe EATHER, F-86000 Poitiers, France
| | - Sandrine Lefeuvre
- Université de Poitiers, CNRS, Laboratoire EBI, Équipe IHES, F-86000 Poitiers, France; CHU de Poitiers, CIC-Inserm, Axe EATHER, F-86000 Poitiers, France
| | - Jérémy Guihenneuc
- Université de Poitiers, CNRS, Laboratoire EBI, Équipe IHES, F-86000 Poitiers, France; CHU de Poitiers, CIC-Inserm, Axe EATHER, F-86000 Poitiers, France
| | - Guillaume Cambien
- Université de Poitiers, CNRS, Laboratoire EBI, Équipe IHES, F-86000 Poitiers, France; CHU de Poitiers, CIC-Inserm, Axe EATHER, F-86000 Poitiers, France
| | - Antoine Dupuis
- Université de Poitiers, CNRS, Laboratoire EBI, Équipe IHES, F-86000 Poitiers, France; CHU de Poitiers, CIC-Inserm, Axe EATHER, F-86000 Poitiers, France
| | - Nicolas Venisse
- Université de Poitiers, CNRS, Laboratoire EBI, Équipe IHES, F-86000 Poitiers, France; CHU de Poitiers, CIC-Inserm, Axe EATHER, F-86000 Poitiers, France.
| |
Collapse
|
2
|
Robin J, Albouy M, Jourdain B, Binson G, Sauvaget A, Pierre-Eugène P, Wu L, Migeot V, Dupuis A, Venisse N. Assessment of Endocrine Disruptor Exposure in Hospital Professionals Using Hair and Urine Analyses: An Awareness Campaign. Ther Drug Monit 2024; 46:102-110. [PMID: 37559216 DOI: 10.1097/ftd.0000000000001132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2023] [Accepted: 06/04/2023] [Indexed: 08/11/2023]
Abstract
BACKGROUND In 2021, French public authorities initiated the fourth National Environmental Health Plan to prevent environment-related health risks. This plan primarily focuses on the sensitization of health professionals and health care institutions. Endocrine disruptors (EDs) are environmental factors associated with several adverse health effects, such as reproductive disorders, obesity, and cancer. This study aimed to conduct an awareness campaign among professionals at a general hospital center on the risks related to EDs. METHODS Hospital professionals were directly involved in this study, and urine and hair samples were collected to determine bisphenol and paraben exposure levels. Analyses were performed using validated liquid chromatography-tandem mass spectrometry methods, enabling the simultaneous determination of bisphenols and parabens. A questionnaire on lifestyle habits was distributed to assess its relationship with the exposure profiles. Nineteen professionals were recruited for the study. RESULTS Bisphenol A was detected in 95% of the urine samples, and the chlorinated derivatives of bisphenol A were between 16% and 63%. parabens showed detection frequencies between 37% and 100%, and methylparaben was quantified at an average concentration of 0.45 ± 0.46 ng/mL. In hair samples, bisphenols A, F, and S were detected at 95%-100%, chlorinated derivatives of bisphenol A were detected at 37%-68%, and parabens were detected at 100%. CONCLUSIONS This awareness campaign may encourage health care institutions to adopt a policy of reducing endocrine disruptor exposure among their patients and professionals, who could be educated regarding the risks associated with EDs. Conducting a multicenter study to refine the results herein and establish a dynamic to prevent endocrine disruptor and environmental risks in health care systems would be valuable.
Collapse
Affiliation(s)
- Julien Robin
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| | - Marion Albouy
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | | | - Guillaume Binson
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Alexis Sauvaget
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| | - Pascale Pierre-Eugène
- INSERM, Clinical Investigation Center 1402
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Luyao Wu
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| | - Virginie Migeot
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Antoine Dupuis
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
- School of Medicine and Pharmacy, University of Poitiers, Poitiers; and
| | - Nicolas Venisse
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers
- INSERM, Clinical Investigation Center 1402
- CNRS UMR 7267, Écologie et Biologie des Interactions, University of Poitiers
| |
Collapse
|
3
|
Cambien G, Dupuis A, Belmouaz M, Bauwens M, Bacle A, Ragot S, Migeot V, Albouy M, Ayraud-Thevenot S. Bisphenol A and chlorinated derivatives of bisphenol A assessment in end stage renal disease patients: Impact of dialysis therapy. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 2024; 270:115880. [PMID: 38159342 DOI: 10.1016/j.ecoenv.2023.115880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 09/25/2023] [Accepted: 12/20/2023] [Indexed: 01/03/2024]
Abstract
Patients with end stage kidney disease treated by dialysis (ESKDD) process dialysis sessions to remove molecules usually excreted by kidneys. However, dialysis therapy could also contribute to endocrine disruptors (ED) burden. Indeed, materials like dialyzer filters, ultrapure dialysate and replacement fluid could exposed ESKDD patients to Bisphenol A (BPA) and chlorinated derivatives of BPA (ClxBPAs). Thus, our aim was to compare BPA and ClxBPAs exposure between ESKDD patients, patients with stage 5 chronic kidney disease (CKD5) not dialyzed and healthy volunteers. Then we describe the impact of a single dialysis session, according to dialysis modalities (hemodialysis therapy (HD) versus online hemodiafiltration therapy (HDF)) and materials used with pre-post BPA and ClxBPAs concentrations. The plasma levels of BPA and four ClxBPAs, were assessed for 64 ESKDD patients in pre and post dialysis samples (32 treated by HD and 32 treated by HDF) in 36 CKD5 patients and in 24 healthy volunteers. BPA plasma concentrations were 22.5 times higher for ESKDD patients in pre-dialysis samples versus healthy volunteers (2.208 ± 5.525 ng/mL versus 0.098 ± 0.169 ng/mL) (p < 0.001). BPA plasma concentrations were 16 times higher for CKD5 patients versus healthy volunteers, but it was not significant (1.606 ± 3.230 ng/mL versus 0.098 ± 0.169 ng/mL) (p > 0.05). BPA plasma concentrations for ESKDD patients in pre-dialysis samples were 1.4 times higher versus CKD5 patients (2.208 ± 5.525 ng/mL versus 1.606 ± 3.230 ng/mL) (p < 0.001). For healthy volunteers, ClxBPAs were never detected, or quantified while for CKD5 and ESKDD patients one ClxBPAs at least has been detected or quantified in 14 patients (38.8%) and 24 patients (37.5%), respectively. Dialysis therapy was inefficient to remove BPA either for HD (1.983 ± 6.042 ng/mL in pre-dialysis versus 3.675 ± 8.445 ng/mL in post-dialysis) or HDF (2.434 ± 5.042 ng/mL in pre-dialysis versus 7.462 ± 15.960 ng/mL in post dialysis) regarding pre-post BPA concentrations (p > 0.05). The same result was observed regarding ClxBPA analysis. Presence of polysulfone in dialyzer fibers overexposed ESKDD patients to BPA in pre-dialysis samples with 3.054 ± 6.770 for ESKDD patients treated with a polysulfone dialyzer versus 0.708 ± 0.638 (p = 0.040) for ESKDD patients treated without a polysulfone dialyzer and to BPA in post-dialysis samples with 6.629 ± 13.932 for ESKDD patients treated with a polysulfone dialyzer versus 3.982 ± 11.004 (p = 0.018) for ESKDD patients treated without a polysulfone dialyzer. This work is to our knowledge the first to investigate, the impact of a dialysis session and materials used on BPA and ClxBPAs plasma concentrations and to compare these concentrations to those found in CKD5 patients and in healthy volunteers.
Collapse
Affiliation(s)
- Guillaume Cambien
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| | - Antoine Dupuis
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| | - Mohamed Belmouaz
- CHU de Poitiers, Digestiv, Urology, Nephrology, Endocrinology Department, F-86000 Poitiers, France.
| | - Marc Bauwens
- CHU de Poitiers, Digestiv, Urology, Nephrology, Endocrinology Department, F-86000 Poitiers, France.
| | - Astrid Bacle
- CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000 Rennes, France; Pôle Pharmacie, Service Hospitalo-Universitaire de Pharmacie, CHU Rennes, 35000, Rennes, France.
| | - Stéphanie Ragot
- Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe SCALE-EPI, Poitiers, France.
| | - Virginie Migeot
- CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-35000 Rennes, France; CHU Rennes, Epidemiology and Public Health Department, F-35000 Rennes, France.
| | - Marion Albouy
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| | - Sarah Ayraud-Thevenot
- Université de Poitiers, CNRS, EBI, F-86000 Poitiers, France; Université de Poitiers, CHU de Poitiers, INSERM, Centre d'investigation Clinique CIC1402, Axe santé Environnementale, Poitiers, France; CHU de Poitiers, Biology-Pharmacy-Public Health Department, F-86000 Poitiers, France.
| |
Collapse
|
4
|
Plattard N, Gnanasegaran R, Krekesheva A, Carato P, Dupuis A, Migeot V, Albouy M, Haddad S, Venisse N. Quantification of the Conjugated Forms of Dichlorobisphenol A (3,3'-Cl 2 BPA) in Rat and Human Plasma Using HPLC-MS/MS. Ther Drug Monit 2023; 45:554-561. [PMID: 36649713 DOI: 10.1097/ftd.0000000000001074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2022] [Accepted: 10/28/2022] [Indexed: 01/19/2023]
Abstract
BACKGROUND Bisphenol A (BPA) is a ubiquitous contaminant that has endocrine-disrupting effects. Chlorinated derivatives of BPA are formed during chlorination of drinking water and have higher endocrine-disrupting activity. Dichlorobisphenol A (Cl 2 BPA) is the most abundant chlorinated BPA derivative found in several human biological matrices. Recent in vitro experiments have shown that Cl 2 BPA is metabolized in sulpho- and glucuro-conjugated compounds. To date, no assay has been developed to quantify the sulfo- and glucuro-conjugates of 3,3'-Cl 2 BPA (3,3'-Cl 2 BPA-S and 3,3'-Cl 2 BPA-G, respectively). METHODS A high-performance liquid chromatography-tandem mass spectrometry assay for the determination of 3,3'-Cl 2 BPA conjugated forms in plasma samples was developed and validated according to the European Medicines Agency guidelines. Quantification was performed in the multiple reaction monitoring mode for all target analytes using a SCIEX 6500 + tandem mass spectrometer with an electrospray source operating in the negative ionization mode. Chromatographic separation was achieved using a C18 column maintained at 40°C and a binary mobile phase delivered in the gradient mode at a flow rate of 0.35 mL/min. Sample was prepared via simple precipitation using acetonitrile. The assay was validated and applied to rat and human plasma samples. RESULTS Linearity was demonstrated over the range of 0.006-25 ng/mL for 3,3'-Cl 2 BPA-G and 0.391-100 ng/mL for 3,3'-Cl 2 BPA-S. Intraday and interday bias values were in the 95%-109% range, and the imprecision <9%. Internal standard corrected matrix effects were also investigated. This method enabled quantification of the conjugated forms of 3,3'-Cl 2 BPA in plasma samples. CONCLUSIONS This is the first report on the development and validation of an analytical method for the quantification of 3,3'-Cl 2 BPA-G and 3,3'-Cl 2 BPA-S in the plasma matrix. This study is also the first report on the in vivo occurrence of these metabolites.
Collapse
Affiliation(s)
- Noemie Plattard
- Department of Environmental and Occupational Health, School of Public Health, CresP, Université de Montréal, Montreal, Quebec, Canada
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Riciga Gnanasegaran
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Aida Krekesheva
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Pascal Carato
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
| | - Antoine Dupuis
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| | - Virginie Migeot
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| | - Marion Albouy
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| | - Sami Haddad
- Department of Environmental and Occupational Health, School of Public Health, CresP, Université de Montréal, Montreal, Quebec, Canada
| | - Nicolas Venisse
- CHU Poitiers, INSERM CIC1402, Université de Poitiers, CNRS 7267 EBI, Poitiers, France; and
- Biology-Pharmacy-Public Health Department, CHU de Poitiers, Poitiers Cedex, France
| |
Collapse
|
5
|
Robin J, Binson G, Albouy M, Sauvaget A, Pierre-Eugène P, Migeot V, Dupuis A, Venisse N. Analytical method for the biomonitoring of bisphenols and parabens by liquid chromatography coupled to tandem mass spectrometry in human hair. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 2022; 243:113986. [PMID: 36027714 DOI: 10.1016/j.ecoenv.2022.113986] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Revised: 07/05/2022] [Accepted: 08/14/2022] [Indexed: 05/22/2023]
Abstract
Bisphenols and parabens are endocrine disruptors families widely used in daily life. They are known to be linked to numerous pathologies such as reproductive disorders, obesity, breast cancer, hypertension and asthma. Biomonitoring is an essential tool for assessing population exposure to environmental pollutants. Blood and urine are the main matrices used in human biomonitoring. However, they are not suitable to evaluate long-term exposure to endocrine disruptors with a short elimination half-life such as parabens or phenols. Hair appears to be an interesting alternative matrix allowing a wide window of exposure due to an accumulation of xenobiotics during hair growth. This study presents the development and validation of a high-performance liquid chromatography coupled to tandem mass spectrometry for the simultaneous determination of bisphenol A, its chlorinated derivatives, bisphenol F, bisphenol S and parabens in human hair. An optimised sample preparation based on acidic hydrolysis followed by liquid-liquid extraction was performed, before an analysis by ultra-high performance liquid chromatography coupled to tandem mass spectrometry in multiple reaction monitoring mode. To validate the method, recognized bioanalytical guidelines were used and calibration and quality control samples were prepared in human hair samples. Linearities were over 0.996 in the whole range of concentrations. Trueness and precision were demonstrated for each target analyte with intra-day and inter-day bias values ranging from 86 % to 118 % and relative standard deviation values ranging from 0 % to 19 %. At the same time, limits of quantification were set at 0.25 ng/g for bisphenol A and parabens, 0.05 ng/g for bisphenols F and S and 0.00625 ng/g for the chlorinated derivatives of bisphenol A. This reliable method was applied to hair samples taken from hospital professionals and allowed the quantification of these endocrine disruptors in this population. Chlorinated derivatives of bisphenol A were quantified here in hair for the first time.
Collapse
Affiliation(s)
- Julien Robin
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Guillaume Binson
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Marion Albouy
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Alexis Sauvaget
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Pascale Pierre-Eugène
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Virginie Migeot
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Antoine Dupuis
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculté de Médecine et Pharmacie, Université de Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Nicolas Venisse
- Université de Poitiers, CHU Poitiers, CNRS 7267 EBI, INSERM CIC 1402, F-86000, Poitiers, France; Pôle Biologie - Pharmacie, Santé Publique, CHU de Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France.
| |
Collapse
|
6
|
Hwang E, Lee B. Synthesis of a fluorescence sensor based on carbon quantum dots for detection of bisphenol A in aqueous solution. KOREAN J CHEM ENG 2022. [DOI: 10.1007/s11814-021-0989-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
7
|
El Ouazzani H, Fortin S, Venisse N, Dupuis A, Rouillon S, Cambien G, Gourgues AS, Pierre-Eugène P, Rabouan S, Migeot V, Albouy-Llaty M. Perinatal Environmental Health Education Intervention to Reduce Exposure to Endocrine Disruptors: The PREVED Project. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 19:ijerph19010070. [PMID: 35010328 PMCID: PMC8750995 DOI: 10.3390/ijerph19010070] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Revised: 12/17/2021] [Accepted: 12/19/2021] [Indexed: 05/21/2023]
Abstract
Environmental health promotion interventions may reduce endocrine disruptor (ED) exposure. The PREVED (PREgnancy, preVention, Endocrine Disruptors) project was developed to improve knowledge, to enhance risk perception, and to change exposure behavior. Our objective was to present the phases of the PREVED project using the RE-AIM method. PREVED intervention consisted of three workshops during pregnancy. Reach, adoption, and implementation phases were assessed with qualitative studies. Efficacy study consisted of a three-arm randomized controlled trial (RCT) on 268 pregnant women: (i) control group (leaflet), (ii) intervention group in neutral location, (iii) intervention group in contextualized location. The main outcome was the percentage evolution of participants who reported consuming canned food. Secondary outcomes were evolution of psycho-social scores, evolution of ED presence in urine, and ED presence in colostrum. The intervention adoption was centered on upper-privileged women, but implementation assessment showed that key features (highly practical intervention) seemed to be carried out and had initiated some behavior changes. A total of 268 pregnant women participated in the intervention and 230 in a randomized controlled trial (control group: 86 and intervention groups: 172). We found no significant differences in consumption of canned food and in percentage of women having a decrease of bisphenol A or parabens in urine, but we found a significant increase in the evolution of risk perception score and overall psychosocial score in intervention groups (respectively: +15.73 control versus +21.03 intervention, p = 0.003 and +12.39 versus +16.20, p = 0.02). We found a significant difference in percentage of women with butylparaben detection between control group and intervention groups (13% versus 3%, p = 0.03). PREVED intervention is the first intervention research dedicated to perinatal environmental health education in France. By sharing know-how/experience in a positive non-alarmist approach, it improved risk perception, which is key to behavior change, aiming to reduce perinatal ED exposure. Including women in precarious situations remains a major issue.
Collapse
Affiliation(s)
- Houria El Ouazzani
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
| | - Simon Fortin
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
| | - Nicolas Venisse
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Antoine Dupuis
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Steeve Rouillon
- APHP Laboratory of Pharmacology, GH Henri Mondor, 94010 Creteil, France;
| | - Guillaume Cambien
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Anne-Sophie Gourgues
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
| | - Pascale Pierre-Eugène
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Sylvie Rabouan
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
| | - Virginie Migeot
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
| | - Marion Albouy-Llaty
- Center of Clinical Investigation Inserm 1402, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France; (H.E.O.); (S.F.); (N.V.); (A.D.); (G.C.); (P.P.-E.); (S.R.); (V.M.)
- Faculty of Medicine and Pharmacy, University of Poitiers, 6 Rue de la Milétrie, 86031 Poitiers, France
- BioSPharm Pole, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021 Poitiers, France;
- Ecology and Biology of Interaction, CNRS UMR 7267, 86073 Poitiers, France
- Correspondence:
| |
Collapse
|
8
|
Impact of perinatal environmental health education intervention on exposure to endocrine disruptors during pregnancy-PREVED study: study protocol for a randomized controlled trial. Trials 2021; 22:876. [PMID: 34863252 PMCID: PMC8642981 DOI: 10.1186/s13063-021-05813-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Accepted: 11/10/2021] [Indexed: 12/17/2022] Open
Abstract
Background The suspected or actual effects on health of endocrine-disrupting chemicals (EDC) and their ubiquitous presence in everyday life justify the implementation of health promotion interventions. These interventions should ideally be applied during critical windows like pregnancy. Perinatal environmental health education interventions may help to reduce EDC exposure during pregnancy. Methods/design PREVED (Pregnancy, PreVention, Endocrine Disruptors) is an open-label randomized controlled trial assessing the impact of environmental health education intervention on EDC exposure during pregnancy. Inclusion, consent, and randomization take place during the first trimester. The participants are randomly allocated into three groups: (i) control group (information leaflet on EDCs), (ii) intervention group in neutral location (information leaflet and workshops in a meeting room), and (iii) intervention group in contextualized location (information leaflet and workshops in a real apartment). Workshops are organized between the second and third trimesters of pregnancy. Main outcome is the percentage of participants who reported consuming manufactured/industrial food. Secondary outcomes are as follows: (i) psycho-social dimensions, (ii) EDC concentrations in urine, (iii) EDC concentration in colostrum, and (iv) percentage of participants who reported consuming paraben-free personal care products. Discussion PREVED is a ground-breaking intervention research project dedicated to perinatal environmental health education that aims to identify pollutant sources in daily life and to offer accessible and realistic alternative solutions, by promoting the sharing of know-how and experience in a positive and non-alarmist approach. Trial registration ClinicalTrials.gov: NCT03233984 (current status: ongoing). Retrospectively registered on 31 July 2017 (https://clinicaltrials.gov/ct2/show/NCT03233984) because when the first participant was enrolled in this non-drug intervention, ClinicalTrials.gov was centered in therapeutic trials. The World Health Organization Trial Registration Data Set is in Additional file 1. Supplementary Information The online version contains supplementary material available at 10.1186/s13063-021-05813-5.
Collapse
|
9
|
Recent advances in analysis of bisphenols and their derivatives in biological matrices. Anal Bioanal Chem 2021; 414:807-846. [PMID: 34652496 DOI: 10.1007/s00216-021-03668-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2021] [Accepted: 09/14/2021] [Indexed: 10/20/2022]
Abstract
Biomonitoring is a very useful tool to evaluate human exposure to endocrine-disrupting compounds (EDCs), like bisphenols (BPs), which are widely used in the manufacture of plastics. The development of reliable analytical methods is key in the field of public health surveillance to obtain biomonitoring data to determine what BPs are reaching people's bodies. This review discusses recent methods for the quantitative measurement of bisphenols and their derivatives in biological samples like urine, blood, breast milk, saliva, and hair, among others. We also discuss the different procedures commonly used for sample treatment, which includes extraction and clean-up, and instrumental techniques currently used to determine these compounds. Sample preparation techniques continue to play an important role in the analysis of complex matrices, for liquid matrices the most commonly employed is solid-phase extraction, although microextraction techniques are gaining importance in this field, and for solid samples ultrasound-assisted extraction. The main instrumental techniques used are liquid and gas chromatography coupled with mass spectrometry. Finally, we present data on the main parameters obtained in the validation of the revised methods. This review focuses on various methods developed and applied for trace analysis of bisphenols, their conjugates, halogenated derivatives, and diglycidyl ethers in biological samples to enable the required selectivity and sensitivity. For this purpose, a review is carried out of the most recent relevant publications from 2016 up to present.
Collapse
|
10
|
Plattard N, Dupuis A, Migeot V, Haddad S, Venisse N. An overview of the literature on emerging pollutants: Chlorinated derivatives of Bisphenol A (Cl xBPA). ENVIRONMENT INTERNATIONAL 2021; 153:106547. [PMID: 33831741 DOI: 10.1016/j.envint.2021.106547] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 03/23/2021] [Accepted: 03/24/2021] [Indexed: 05/12/2023]
Abstract
CONTEXT Bisphenol A (BPA) is a ubiquitous contaminant with endocrine-disrupting effects in mammals. During chlorination treatment of drinking water, aqueous BPA can react with chlorine to form chlorinated derivatives of BPA (mono, di, tri and tetra-chlorinated derivatives) or ClxBPA. OBJECTIVE The aim of this study is to summarize and present the state of knowledge on human toxicological risk assessment of ClxBPA. MATERIALS AND METHODS A search on ClxBPA in the PubMed database was performed based on studies published between 2002 and 2021. Forty-nine studies on chlorinated derivatives of BPA were found. Available information on their sources and levels of exposure, their effects, their possible mechanisms of action and their toxicokinetics data was extracted and presented. RESULTS ClxBPA have been essentially detected in environmental aqueous media. There is evidence in toxicological and epidemiological studies that ClxBPA also have endocrine-disrupting capabilities. These emerging pollutants have been found in human urine, serum, breast milk, adipose and placental tissue and can constitute a risk to human health. However, in vitro and in vivo toxicokinetic data on ClxBPA are scarce and do not allow characterization of the disposition kinetics of these compounds. CONCLUSION More research to assess their health risks, specifically in vulnerable populations, is needed. Some water chlorination processes are particularly hazardous, and it is important to evaluate their chlorination by-products from a public health perspective.
Collapse
Affiliation(s)
- N Plattard
- Department of Environmental and Occupational Health, School of Public Health, CresP, Université de Montréal, Montreal, Quebec, Canada; INSERM CIC1402, CHU Poitiers, Université de Poitiers, HEDEX Research Group, 86021 Poitiers Cedex, France
| | - A Dupuis
- INSERM CIC1402, CHU Poitiers, Université de Poitiers, HEDEX Research Group, 86021 Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, CHU de Poitiers, 2 rue de la Milétrie, 86201 Poitiers Cedex, France
| | - V Migeot
- INSERM CIC1402, CHU Poitiers, Université de Poitiers, HEDEX Research Group, 86021 Poitiers Cedex, France
| | - S Haddad
- Department of Environmental and Occupational Health, School of Public Health, CresP, Université de Montréal, Montreal, Quebec, Canada
| | - N Venisse
- INSERM CIC1402, CHU Poitiers, Université de Poitiers, HEDEX Research Group, 86021 Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, CHU de Poitiers, 2 rue de la Milétrie, 86201 Poitiers Cedex, France.
| |
Collapse
|
11
|
Novel computer-assisted separation prediction strategy for online-enrichment-HPLC-FLD in simultaneous monitoring of bisphenols in children's water bottles. Food Chem 2020; 339:127766. [PMID: 32866697 DOI: 10.1016/j.foodchem.2020.127766] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Revised: 06/21/2020] [Accepted: 08/02/2020] [Indexed: 01/31/2023]
Abstract
An on-line enrichment-liquid chromatography-fluorescence detection (LC-FD) method was developed for simultaneous determination of nine bisphenols (BPs). In this process, we predicted the separation based on an in-house developed software allowing for calculating both retention time (tR) and half-peak width (W1/2) of the solute by mobile phase fraction (φ) under gradient conditions. The proposed strategy was applied to separation prediction of BPs with high accuracy. Under the optimized conditions, good linearity was obtained with the correlation coefficients (R2) ranging from 0.998 to 1.000. The recoveries in spiked samples were 91.3-110.7% with the intra-day and inter-day relative standard deviation ranging 0.4-9.6% and 0.5-10.2%, respectively. The limits of detection and quantification were 0.13-66.7 ng L-1 and 0.40-200 ng L-1. The developed approach was used to monitor the nine BPs in 28 children's water bottles. The developed method provides an effective way for monitoring bisphenols in other similar matrix.
Collapse
|
12
|
Dupuis A, Rabouan S, Migeot V, Venisse N. BPA and risk assessment. Lancet Diabetes Endocrinol 2020; 8:270-271. [PMID: 32197111 DOI: 10.1016/s2213-8587(20)30069-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Accepted: 02/18/2020] [Indexed: 10/24/2022]
Affiliation(s)
- Antoine Dupuis
- INSERM CIC 1402, HEDEX research group, CHU Poitiers, and School of Medicine and Pharmacy, Université de Poitiers, 86000 Poitiers, France.
| | - Sylvie Rabouan
- INSERM CIC 1402, HEDEX research group, CHU Poitiers, and School of Medicine and Pharmacy, Université de Poitiers, 86000 Poitiers, France
| | - Virginie Migeot
- INSERM CIC 1402, HEDEX research group, CHU Poitiers, and School of Medicine and Pharmacy, Université de Poitiers, 86000 Poitiers, France
| | - Nicolas Venisse
- INSERM CIC 1402, HEDEX research group, CHU Poitiers, and School of Medicine and Pharmacy, Université de Poitiers, 86000 Poitiers, France
| |
Collapse
|
13
|
Cambien G, Venisse N, Migeot V, Rabouan S, Belmouaz M, Binson G, Albouy-Llaty M, Ayraud-Thevenot S, Dupuis A. Simultaneous determination of bisphenol A and its chlorinated derivatives in human plasma: Development, validation and application of a UHPLC-MS/MS method. CHEMOSPHERE 2020; 242:125236. [PMID: 31896187 DOI: 10.1016/j.chemosphere.2019.125236] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Revised: 10/23/2019] [Accepted: 10/25/2019] [Indexed: 06/10/2023]
Abstract
Bisphenol A (BPA) is a well-known ubiquitous chemical found in polycarbonate, polysulfone and epoxy resins, used in mass production for many consumer products. BPA exhibits endocrine disruptor properties that can potentially induce adverse health effects. In aquatic environments, it can react with chlorine to produce chlorinated derivatives (ClxBPAs). ClxBPAs exhibit oestrogenic activity 10 to 105 times higher than BPA itself. Assessing human exposure to endocrine disrupting chemicals is mandatory to assess health risk. Blood, as well as urine matrix, are commonly used to perform human biomonitoring. We therefore developed, fully validated and applied a method based on Ultra High Performance Liquid Chromatography couples to a Triple Quad Mass Spectrometer to determine BPA, monochlorobisphenol A (MCBPA), dichlorobisphenol A (DCBPA), trichlorobisphenol A (TCBPA) and tetrachlorobisphenol A (TTCBPA) in human blood plasma. The European Medicines Agency guidelines for bioanalytical method validation have been applied. Precision and trueness of the method were <15% at medium and high levels of quality control and <20% at the limits of quantification (LOQs). The LOQs were settled at 0.1 ng/mL for BPA, 0.02 ng/mL for TTCBPA and 0.005 ng/mL for MCBPA, DCBPA, and TCBPA. The analytical method was applied to ten patients suffering from end stage renal disease. BPA was quantified in all ten patients while MCBPA, DCBPA and TTCBPA were determined in three and TCBPA in four. In conclusion, we have successfully developed a highly sensitive method to determine BPA and ClxBPAs in human plasma. Thanks to this method, for the first time, we could demonstrate ClxBPAs occurrence in human blood.
Collapse
Affiliation(s)
- Guillaume Cambien
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France.
| | - Nicolas Venisse
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France.
| | - Virginie Migeot
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France.
| | - Sylvie Rabouan
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France.
| | - Mohamed Belmouaz
- Digestiv, Urology, Nephrology, Endocrinology Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France.
| | - Guillaume Binson
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France.
| | - Marion Albouy-Llaty
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France.
| | - Sarah Ayraud-Thevenot
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France.
| | - Antoine Dupuis
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers CEDEX, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de La Milétrie, 86021, Poitiers CEDEX, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France.
| |
Collapse
|
14
|
Hu C, Schöttker B, Venisse N, Limousi F, Saulnier PJ, Albouy-Llaty M, Dupuis A, Brenner H, Migeot V, Hadjadj S. Bisphenol A, Chlorinated Derivatives of Bisphenol A and Occurrence of Myocardial Infarction in Patients with Type 2 Diabetes: Nested Case-Control Studies in Two European Cohorts. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2019; 53:9876-9883. [PMID: 31310111 DOI: 10.1021/acs.est.9b02963] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
A positive association between Bisphenol A (BPA) exposure and coronary heart disease has been shown, but not in patients with type 2 diabetes (T2D). During the treatment of drinking water, chlorination leads to the formation of chlorinated derivatives of Bisphenol A (ClxBPA), that have higher estrogenic activity than BPA. No evidence exists for a relationship between exposure to ClxBPA and myocardial infarction in patients with T2D. The objective of this study was to evaluate the relationship between exposure to BPA, ClxBPA and the occurrence of myocardial infarction (MI) in patients with T2D. Two nested case-control studies in two independent European cohorts were performed. Each case with incident MI during follow-up was matched to one control on age, sex, and personal cardiovascular history in the same cohort. Association between baseline urine concentrations of BPA and of ClxBPA and incident MI was determined. Exposure to BPA was 31% in the ESTHER cohort and 18% in the SURDIAGENE cohort. In a meta-analysis of the two studies, occurrence of MI was significantly associated with urine BPA detection: adjusted OR = 1.97 (1.05-3.70), p = 0.04. Exposure to ClxBPA significantly differed in the SURDIAGENE and ESTHER studies: 24% and 8%, respectively (p = 0.0003). It was very strongly associated with MI in the SURDIAGENE cohort with an adjusted odds ratio (OR) of 14.15 (2.77-72.40) but this association was not replicated in the ESTHER study: adjusted OR: 0.17 (0.02-1.23). Whether these results may be explained by different water chlorination processes in France and Germany, resulting in different ClxBPA exposure levels, requires further investigation.
Collapse
Affiliation(s)
- Chunyun Hu
- CHU Poitiers , Department of Public Health , F-86021 Poitiers , France
- Université de Poitiers , School of Medicine and Pharmacy of Poitiers , F-86073 Poitiers , France
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
| | - Ben Schöttker
- Division of Clinical Epidemiology and Aging Research, Division of Preventive Oncology , German Cancer Research Center (DKFZ) , D-69120 Heidelberg , Germany
- Network Aging Research , D-69115 Heidelberg , Germany
| | - Nicolas Venisse
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
- CHU Poitiers , Department of Toxicology and Pharmacokinetics , F-86021 Poitiers , France
| | - Frédérike Limousi
- CHU Poitiers , Department of Public Health , F-86021 Poitiers , France
- Université de Poitiers , School of Medicine and Pharmacy of Poitiers , F-86073 Poitiers , France
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
| | - Pierre Jean Saulnier
- Université de Poitiers , School of Medicine and Pharmacy of Poitiers , F-86073 Poitiers , France
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
| | - Marion Albouy-Llaty
- CHU Poitiers , Department of Public Health , F-86021 Poitiers , France
- Université de Poitiers , School of Medicine and Pharmacy of Poitiers , F-86073 Poitiers , France
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
| | - Antoine Dupuis
- Université de Poitiers , School of Medicine and Pharmacy of Poitiers , F-86073 Poitiers , France
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
- CHU Poitiers , Department of Pharmacy , F-86021 Poitiers , France
| | - Hermann Brenner
- Division of Clinical Epidemiology and Aging Research, Division of Preventive Oncology , German Cancer Research Center (DKFZ) , D-69120 Heidelberg , Germany
- Network Aging Research , D-69115 Heidelberg , Germany
| | - Virginie Migeot
- CHU Poitiers , Department of Public Health , F-86021 Poitiers , France
- Université de Poitiers , School of Medicine and Pharmacy of Poitiers , F-86073 Poitiers , France
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
| | - Samy Hadjadj
- Université de Poitiers , School of Medicine and Pharmacy of Poitiers , F-86073 Poitiers , France
- INSERM CIC 1402 , CHU Poitiers , F-86021 Poitiers , France
- CHU Poitiers , Department of Endocrinology , F-86021 Poitiers , France
- L'institut du thorax, INSERM, CNRS , Univ Nantes, CHU Nantes , F-44093 Nantes , France
| |
Collapse
|
15
|
Venisse N, Cambien G, Robin J, Rouillon S, Nadeau C, Charles T, Rabouan S, Migeot V, Dupuis A. Development and validation of an LC-MS/MS method for the simultaneous determination of bisphenol A and its chlorinated derivatives in adipose tissue. Talanta 2019; 204:145-152. [PMID: 31357276 DOI: 10.1016/j.talanta.2019.05.103] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2019] [Revised: 05/22/2019] [Accepted: 05/27/2019] [Indexed: 11/24/2022]
Abstract
Bisphenol A (BPA) and its chlorinated derivatives (Clx-BPA) are environmental pollutants exhibiting endocrine-disrupting (ED) properties suspected to be involved in the pathogenesis of hormone-dependent cancers, such as breast and prostate cancers. Due to their lipophilic properties, they may accumulate in adipose tissue which could therefore be a suitable matrix to assess long-term exposure to these compounds and relationships with the tumorigenesis of these cancers. An LC-MS/MS assay for the determination of BPA and Clx-BPA in adipose tissue samples was developed and fully validated according to current bioanalytical validation guidelines. Ionization was achieved using an electrospray source operating in the negative mode and quantification of target analytes was obtained in the multiple reaction monitoring mode. Both standard and quality control (QC) samples were prepared in blank adipose tissue samples. Linearity was demonstrated over the ranges 0.125 to 8.000 and 0.0125-0.8000 ng/mL for BPA and Clx-BPA, respectively. Accuracy and precision were demonstrated over the whole concentration range: intra and inter-day bias values were in the 85-114% range and imprecision of the method did not exceed 14%. Lower limits of quantification were validated using QCs at 0.1250 and 0.0125 ng/mL for BPA and Clx-BPA, respectively. Internal standard-corrected matrix effects were comparable in breast and prostate adipose tissues, demonstrating that this method could be used to reliably assay BPA and Clx-BPA in both tissues. The method was sensitive enough to determine BPA and Clx-BPA in breast adipose tissue obtained from women undergoing breast surgery, enabling identification of different patterns of exposure to these ED chemicals. The method enables the reliable quantification of BPA and Clx-BPA in adipose tissue and could be used to assess long-term exposure to these compounds and potential associations with hormone-dependent cancers.
Collapse
Affiliation(s)
- Nicolas Venisse
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France.
| | - Guillaume Cambien
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France
| | - Julien Robin
- Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France
| | - Steeve Rouillon
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France
| | - Cédric Nadeau
- Department of Gynecology and Obstetrics, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France
| | - Thomas Charles
- Department of Urology, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France
| | - Sylvie Rabouan
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Virginie Migeot
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| | - Antoine Dupuis
- INSERM, University Hospital of Poitiers, University of Poitiers, CIC1402, HEDEX Research Group, 86021, Poitiers Cedex, France; Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, 2 Rue de la Milétrie, 86021, Poitiers Cedex, France; Faculty of Medicine and Pharmacy, University of Poitiers, TSA 51115, 86073, Poitiers Cedex, France
| |
Collapse
|
16
|
Doumas M, Rouillon S, Venisse N, Nadeau C, Pierre Eugene P, Farce A, Chavatte P, Dupuis A, Migeot V, Carato P. Chlorinated and brominated bisphenol A derivatives: Synthesis, characterization and determination in water samples. CHEMOSPHERE 2018; 213:434-442. [PMID: 30243209 DOI: 10.1016/j.chemosphere.2018.09.061] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Revised: 09/10/2018] [Accepted: 09/11/2018] [Indexed: 06/08/2023]
Abstract
Bisphenol A (BPA) has been used in the plastics industry for several decades. During the treatment of drinking water with chlorine reagent, the formation of chlorinated derivatives of BPA (ClxBPA) but also bromoBPA and bromochloroBPA is to be expected. Some of these compounds are considered to have an estrogenic effect and could induce major risks for human health by targeting different organs and systems in the body. In this paper, we describe the synthesis of chloro- and bromobisphenol A (ClxBPA, BrxBPA, BrxClxBPA)and their analytical characterization. These derivatives could be used as analytical standards in LC-MS/MS or evaluated in in vitro biological tests for their potential as endocrine disruptors. In this study, we evaluated the presence of BPA, ClxBPA in a pilot study from water samples. Range values found for BPA, ClxBPA were respectively 2.8-4169.3 ng/L and 0.8-11.3 ng/L.
Collapse
Affiliation(s)
- Manon Doumas
- Université de Poitiers, F-86000, Poitiers, France; IC2MP, CNRS, 7285, UFR Médecine Pharmacie, Poitiers, France; CIC INSERM, 1402, UFR Médecine Pharmacie, Poitiers, France.
| | - Steeve Rouillon
- Université de Poitiers, F-86000, Poitiers, France; CIC INSERM, 1402, UFR Médecine Pharmacie, Poitiers, France.
| | - Nicolas Venisse
- CIC INSERM, 1402, UFR Médecine Pharmacie, Poitiers, France; Service de Toxicologie et Pharmacocinétique, CHU, Poitiers, France.
| | - Cedric Nadeau
- Service de Gynécologie Obstétrique, CHU, Poitiers, France.
| | - Pascale Pierre Eugene
- Université de Poitiers, F-86000, Poitiers, France; CIC INSERM, 1402, UFR Médecine Pharmacie, Poitiers, France.
| | - Amaury Farce
- Univ. Lille, Inserm, CHU Lille, U995 - LIRIC - Lille Inflammation Research International Center, Lille, France.
| | - Philippe Chavatte
- Univ. Lille, Inserm, CHU Lille, U995 - LIRIC - Lille Inflammation Research International Center, Lille, France.
| | - Antoine Dupuis
- Université de Poitiers, F-86000, Poitiers, France; CIC INSERM, 1402, UFR Médecine Pharmacie, Poitiers, France; Service de Pharmacie, CHU, Poitiers, France.
| | - Virginie Migeot
- Université de Poitiers, F-86000, Poitiers, France; CIC INSERM, 1402, UFR Médecine Pharmacie, Poitiers, France; Pole Biospharm Service de Santé Publique, CHU, Poitiers, France.
| | - Pascal Carato
- Université de Poitiers, F-86000, Poitiers, France; CIC INSERM, 1402, UFR Médecine Pharmacie, Poitiers, France.
| |
Collapse
|
17
|
Recent advances in biological sample preparation methods coupled with chromatography, spectrometry and electrochemistry analysis techniques. Trends Analyt Chem 2018. [DOI: 10.1016/j.trac.2018.02.005] [Citation(s) in RCA: 94] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|